Corbus Pharmaceuticals Holdings Inc. (NASDAQ:CRBP) has a beta value of 1.8 and has seen 1,670,410 shares traded in the last trading session. The company, currently valued at $215.06 Million, closed the last trade at $1.72 per share which meant it lost -$0.08 on the day or -4.44% during that session. The CRBP stock price is -468.61% off its 52-week high price of $9.78 and 47.09% above the 52-week low of $0.91. If we look at the company’s 10-day average daily trading volume, we find that it stood at 3.07 Million shares traded. The 3-month trading volume is 14.87 Million shares.
The consensus among analysts is that Corbus Pharmaceuticals Holdings Inc. (CRBP) is a Hold stock at the moment, with a recommendation rating of 2.8. None of the analysts rate the stock as a Sell, while none rate it as Overweight. 4 out of 5 have rated it as a Hold, with 1 advising it as a Buy. None have rated the stock as Underweight. The expected earnings per share for the stock is -$0.15.
Corbus Pharmaceuticals Holdings Inc. (NASDAQ:CRBP) trade information
Despite being -4.44% in the red in last session, the stock has traded in the green over the last five days, with the highest price hit on Wednesday, Apr 28 when the CRBP stock price touched $1.92 or saw a rise of 10.42%. Year-to-date, Corbus Pharmaceuticals Holdings Inc. shares have moved 37.6%, while the 5-day performance has seen it change -7.53%. Over the past 30 days, the shares of Corbus Pharmaceuticals Holdings Inc. (NASDAQ:CRBP) have changed -16.1%. Short interest in the company has seen 13.44 Million shares shorted with days to cover at 0.9.
Wall Street analysts have a consensus price target for the stock at $2.37, which means that the shares’ value could jump 37.79% from current levels. The projected low price target is $2 while the price target rests at a high of $3. In that case, then, we find that the current price level is +74.42% off the targeted high while a plunge would see the stock lose 16.28% from current levels.
Corbus Pharmaceuticals Holdings Inc. (CRBP) estimates and forecasts
Figures show that Corbus Pharmaceuticals Holdings Inc. shares have outperformed across the wider relevant industry. The company’s shares have gained +74.8% over the past 6 months, with this year growth rate of 63.38%, compared to 16.6% for the industry. Other than that, the company has, however Increased its growth outlook for the 2021 fiscal year revenue. Growth estimates for the current quarter are 65.1% and 75% for the next quarter. Revenue growth from the last financial year stood is estimated to be -2.5%.
4 analysts offering their estimates for the company have set an average revenue estimate of $960Million for the current quarter. 4 have an estimated revenue figure of $950Million for the next quarter concluding in June 01, 2021. Year-ago sales stood $1.76 Million and $286Million respectively for this quarter and the next, and analysts expect sales will grow by -45.5% for the current quarter and 232.2% for the next.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was -38.2% over the past 5 years. Earnings growth for 2021 is a modest -27.4%.
Even if you’re not actively in crypto, you deserve to know what’s actually going on...
Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.
Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free.
Corbus Pharmaceuticals Holdings Inc. (NASDAQ:CRBP)’s Major holders
Insiders own 1.16% of the company shares, while shares held by institutions stand at 33.7% with a share float percentage of 34.09%. Investors are also buoyed by the number of investors in a company, with Corbus Pharmaceuticals Holdings Inc. having a total of 147 institutions that hold shares in the company. The top two institutional holders are ETF Managers Group, LLC with over 8.1 Million shares worth more than $10.13 Million. As of December 30, 2020, ETF Managers Group, LLC held 6.48% of shares outstanding.
The other major institutional holder is Blackrock Inc., with the holding of over 5.22 Million shares as of December 30, 2020. The firm’s total holdings are worth over $6.53 Million and represent 4.18% of shares outstanding.
Also the top two Mutual Funds that are holding company’s shares are ETF Managers Tr-EFTMG Alternative Harvest ETF and Global X Fds-The Global X Cannabis ETF. As of December 30, 2020, the former fund manager holds about 6.48% shares in the company for having 8103641 shares of worth $10.13 Million while later fund manager owns 2.64 Million shares of worth $5.21 Million as of March 30, 2021, which makes it owner of about 2.12% of company’s outstanding stock.